Jessica N. Holtzman

Jun 10, 2024 | jamanetwork.com | Jessica N. Holtzman |Rita F. Redberg

The safety and effectiveness of high-risk medical devices, such as transcatheter valves, neuromuscular stimulators, and orthopedic implants, warrant rigorous review. For more than 4 decades, the US Food and Drug Administration (FDA) has played the central role of evaluating the effectiveness of novel tests, drugs, and medical devices. The FDA’s purpose is to protect the public from unnecessary harm.

Aug 31, 2023 | atherosclerosis-journal.com | Jessica N. Holtzman |Martha Gulati

Highlights•Disparities in management of ASCVD persist between men and women. •Women experience disproportionate delays in the treatment of ACS. •Women receive less guideline-directed medical therapy despite similar efficacy. •Inadequate enrollment of women in clinical trials contributes to treatment gaps. AbstractDisparities between women and men persist in the diagnosis, treatment, and prognosis of atherosclerotic cardiovascular disease (ASCVD).